This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR Keywords: United Therapeutics, …
Biotechnology company United Therapeutics Corporation (UTHR), Tuesday, reported a narrower loss for the ... Per-share data have been adjusted to reflect a two-for-one stock split effected on September 22, 2009. Total revenue grew to …
United Thera (Nasdaq: UTHR) 18.39% HIGHER; beat Q2 EPS by 16 cents. VI Tech (Nasdaq: VITX) 18.15% HIGHER; SG Cowen stated coverage the stock; tellings clinets to buy. Herbalife (NYSE: HLF) 15.04% HIGHER; guided FY higher. …
Non-GAAP earnings is defined as net income, adjusted for: (1) share-based compensation expense (including expenses relating to stock options ... future events or any other reason. [uthr-g] Orenitram, Remodulin, Tyvaso and Unituxin are …
Oct 23 (Reuters) - United Therapeutics Corp :United Therapeutics announces FDA approval of third generation nebulizer …
NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating …
NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating …
NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating …
News91mon
United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $137.23 to a high of $142.18. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $140.43 on volume of 143,000 …